Jerini Overview
- Year Founded
-
1984
- Status
-
Acquired/Merged
- Employees
-
65
- Latest Deal Type
-
M&A
- Financing Rounds
-
4
Jerini General Information
Description
Developer and marketer of peptide-based drugs. The company offers Firazyr (Icatibant) for the treatment of acute attacks of hereditary angioedema. Its developing product pipeline includes JSM 6427, a a5ß1 Integrin antagonist for the treatment of cancer, age-related mascular degeneration-blindness in the elderly, and angiogenesis, inflammation, and fibrosis; and JSM-7717 and JPE-1375, which are C5a receptor antagonists for the treatment of inflammatory and ophthalmological diseases.
Contact Information
Website
www.jerini.deCorporate Office
- Invalidenstrasse 130
- 10115 Berlin
- Germany
Corporate Office
- Invalidenstrasse 130
- 10115 Berlin
- Germany
Jerini Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Jerini Patents
Jerini Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-2752190-A1 | Small molecule bradykinin b1 receptor antagonists | Inactive | 13-Feb-2009 | ||
| EP-2396301-A2 | Small molecule bradykinin b1 receptor antagonists | Inactive | 13-Feb-2009 | ||
| WO-2010091876-A2 | Small molecule bradykinin b1 receptor antagonists | Inactive | 13-Feb-2009 | ||
| WO-2010091876-A3 | Small molecule bradykinin b1 receptor antagonists | Inactive | 13-Feb-2009 | ||
| EP-2344477-A1 | Small molecule bradykinin b2 receptor modulators | Inactive | 22-Sep-2008 | C07D401/14 |
Jerini Signals
Jerini Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Jerini FAQs
-
When was Jerini founded?
Jerini was founded in 1984.
-
Where is Jerini headquartered?
Jerini is headquartered in Berlin, Germany.
-
What is the size of Jerini?
Jerini has 65 total employees.
-
What industry is Jerini in?
Jerini’s primary industry is Drug Discovery.
-
Is Jerini a private or public company?
Jerini is a Private company.
-
What is the current valuation of Jerini?
The current valuation of Jerini is .
-
What is Jerini’s current revenue?
The current revenue for Jerini is .
-
How much funding has Jerini raised over time?
Jerini has raised $101M.
-
Who are Jerini’s investors?
3i Group, EQT Life Sciences, Edelman Financial Engines, HealthCap, and IBB Ventures are 5 of 14 investors who have invested in Jerini.
-
When was Jerini acquired?
Jerini was acquired on 03-Jul-2008.
-
Who acquired Jerini?
Jerini was acquired by Shire (Pharmaceuticals).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process